Heraeus Precious Metals’ multi-million Euro investment is in response to the global increase in demand for cancer drugs while consolidating its position as the global market leader for platinum-based active ingredients.
The business line Pharmaceutical Ingredients began building the new production line in accordance with the latest EHS and GMP requirements at its headquarters in Hanau at the end of 2018. Today the new production line is running at full speed, and customers have already received the first deliveries of active ingredients.
“We are proud to have brought this project to a successful conclusion in such a short time. Our customers can now benefit from our additional capacity and shorter delivery times for top-quality active ingredients,” says Marcus Hannakam, Head of Pharmaceutical Ingredients.